Option Care Health, Inc. (NASDAQ:OPCH) Receives Average Recommendation of “Moderate Buy” from Analysts

Shares of Option Care Health, Inc. (NASDAQ:OPCH) have been given a consensus recommendation of “Moderate Buy” by the eleven ratings firms that are currently covering the stock, MarketBeat Ratings reports. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating on the company. The average 12 month price objective among brokerages that have updated their coverage on the stock in the last year is $37.2727.

OPCH has been the subject of a number of recent research reports. National Bank Financial set a $37.00 price target on Option Care Health in a research report on Tuesday, January 27th. Truist Financial set a $40.00 price objective on shares of Option Care Health in a report on Tuesday, January 13th. Bank of America boosted their price objective on shares of Option Care Health from $32.00 to $35.00 and gave the stock a “buy” rating in a research report on Tuesday, December 9th. Wall Street Zen downgraded shares of Option Care Health from a “buy” rating to a “hold” rating in a research report on Saturday, February 28th. Finally, Morgan Stanley lifted their price target on shares of Option Care Health from $35.00 to $38.00 and gave the company an “overweight” rating in a research note on Tuesday, January 13th.

Option Care Health Stock Performance

OPCH opened at $28.41 on Thursday. The company has a market capitalization of $4.44 billion, a price-to-earnings ratio of 22.20, a P/E/G ratio of 1.58 and a beta of 0.85. The business’s 50-day moving average price is $33.21 and its two-hundred day moving average price is $30.76. Option Care Health has a 1 year low of $24.24 and a 1 year high of $36.80. The company has a debt-to-equity ratio of 0.87, a current ratio of 1.53 and a quick ratio of 0.96.

Option Care Health (NASDAQ:OPCH) last posted its quarterly earnings data on Tuesday, February 24th. The company reported $0.46 earnings per share for the quarter, hitting the consensus estimate of $0.46. The company had revenue of $1.47 billion during the quarter, compared to analysts’ expectations of $1.46 billion. Option Care Health had a return on equity of 18.57% and a net margin of 3.67%.Option Care Health’s revenue for the quarter was up 8.8% compared to the same quarter last year. During the same period in the prior year, the firm earned $0.44 earnings per share. Equities analysts expect that Option Care Health will post 1.22 EPS for the current fiscal year.

Institutional Trading of Option Care Health

A number of hedge funds and other institutional investors have recently modified their holdings of OPCH. Durable Capital Partners LP boosted its position in Option Care Health by 134.2% during the second quarter. Durable Capital Partners LP now owns 8,237,577 shares of the company’s stock valued at $267,557,000 after purchasing an additional 4,720,988 shares during the last quarter. Fuller & Thaler Asset Management Inc. grew its stake in Option Care Health by 12.1% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 6,958,800 shares of the company’s stock valued at $221,707,000 after purchasing an additional 752,058 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Option Care Health by 6.2% during the 4th quarter. Arrowstreet Capital Limited Partnership now owns 4,248,425 shares of the company’s stock worth $135,355,000 after purchasing an additional 247,118 shares during the last quarter. Dimensional Fund Advisors LP increased its position in shares of Option Care Health by 1.2% during the 4th quarter. Dimensional Fund Advisors LP now owns 3,840,648 shares of the company’s stock worth $122,367,000 after purchasing an additional 44,252 shares during the last quarter. Finally, Morgan Stanley raised its stake in shares of Option Care Health by 13.3% during the 4th quarter. Morgan Stanley now owns 3,410,233 shares of the company’s stock worth $108,650,000 after purchasing an additional 400,740 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.